Correlation Between Apollomics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Apollomics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apollomics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apollomics Class A and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Apollomics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apollomics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apollomics and Sonnet Biotherapeutics.
Diversification Opportunities for Apollomics and Sonnet Biotherapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Apollomics and Sonnet is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Apollomics Class A and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Apollomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apollomics Class A are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Apollomics i.e., Apollomics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Apollomics and Sonnet Biotherapeutics
Given the investment horizon of 90 days Apollomics Class A is expected to generate 1.04 times more return on investment than Sonnet Biotherapeutics. However, Apollomics is 1.04 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.13 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.1 per unit of risk. If you would invest 929.00 in Apollomics Class A on September 13, 2025 and sell it today you would earn a total of 742.00 from holding Apollomics Class A or generate 79.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 90.48% |
| Values | Daily Returns |
Apollomics Class A vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Apollomics Class A |
| Sonnet Biotherapeutics |
Risk-Adjusted Performance
Weakest
Weak | Strong |
Apollomics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apollomics and Sonnet Biotherapeutics
The main advantage of trading using opposite Apollomics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apollomics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Apollomics vs. LMF Acquisition Opportunities | Apollomics vs. Moleculin Biotech | Apollomics vs. Athira Pharma | Apollomics vs. Lunai Bioworks |
| Sonnet Biotherapeutics vs. Rallybio Corp | Sonnet Biotherapeutics vs. TAO Synergies | Sonnet Biotherapeutics vs. Klotho Neurosciences, | Sonnet Biotherapeutics vs. Exicure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |